Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva-Reference-Cited by-同舟云学术

Permanent heterotopic ossification at the injection site after diphtheria-tetanus-pertussis immunizations in children who have fibrodysplasia ossificans progressiva

Published:1995-05 Issue:5 Volume:126 Page:762-764
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Lanchoney Thomas F.,Cohen Randolph B.,Rocke David M.,Zasloff Michael A.,Kaplan Frederick S.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference14 articles.

1. Age and joint specific risk of initial heterotopic ossification in patients who have fibrodysplasia ossificans progressiva;Rocke;Clin Orthop Rel Res,1994

2. Fibrodysplasia ossificans progressiva: the clinical features and natural history of thirty-four patients;Connor;J Bone Joint Surg,1982

3. Genetic transmission of fibrodysplasia ossificans progressiva: a report of a family;Kaplan;J Bone Joint Surg,1993

4. The histopathology of fibrodysplasia ossificans progressiva: an endochondral process;Kaplan;J Bone Joint Surg,1993

5. The natural history of fibrodysplasia ossificans progressiva: a study of forty-four patients;Cohen;J Bone Joint Surg,1993

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva;Science Translational Medicine;2024-05-29

2. A follow-up report on the published paper Social and clinical impact of COVID-19 on patients with fibrodysplasia ossificans progressiva;Orphanet Journal of Rare Diseases;2023-03-20

3. Patient-nurse ratio as an index related to healthcare-associated infections: a surveillance study;Boletín Médico del Hospital Infantil de México;2023-03-03

4. Fibrodysplasia Ossificans Progressiva: Literature Review and Case Report;Current Pediatrics;2023-01-20

5. SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients;Frontiers in Immunology;2022-11-09